XML 49 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Cash flows (used in) provided by operating activities:            
Net income $ 29,089   $ 62,217 $ 158,271 $ 166,996  
Adjustments to reconcile net income to net cash provided by operating activities:            
Amortization of discount/premium and PIK       (61,949) (46,103)  
Amortization of deferred financing costs       8,535 8,204  
Equity-based compensation       7,084 6,672  
Provision for loan losses and impairments, net of reversal 35,000   0 20,000 5,000  
Realized loss on investments       12,513 0  
Foreign currency loss       22,111 22,162  
Unrealized (gain) loss on derivative instruments       11,391 (20,986)  
Loss on early extinguishment of debt       0 2,573  
Changes in operating assets and liabilities:            
Proceeds received from PIK       11,469 75,652  
Other assets       (4,216) (8,476)  
Accounts payable, accrued expenses and other liabilities       2,462 8,087  
Payable to related party       630 1,347  
Net cash (used in) provided by operating activities       188,301 221,128  
Cash flows used in investing activities:            
New funding of commercial mortgage loans       (1,277,606) (1,382,440)  
Add-on funding of commercial mortgage loans       (271,720) (90,201)  
New funding of subordinate loans and other lending assets       (493,017) (207,683)  
Add-on funding of subordinate loans and other lending assets       (18,323) (84,852)  
Proceeds and payments received on commercial mortgage loans       570,305 356,865  
Proceeds and payments received on subordinate loans and other lending assets, net       254,019 463,524  
Origination and exit fees received on commercial mortgage loans, and subordinate loans and other lending assets, net       24,524 32,473  
(Decrease) Increase in collateral held related to derivative contracts       (19,830) 4,930  
Net cash (used in) provided by investing activities       (1,231,648) (907,384)  
Cash flows from financing activities:            
Proceeds from issuance of common stock       315,157 275,879  
Redemption of preferred stock       (172,500) 0  
Payment of offering costs       (153) (199)  
Proceeds from secured debt arrangements       1,948,037 1,623,186  
Repayments of secured debt arrangements       (1,264,223) (941,662)  
Repayments of senior secured term loan principal (1,300)     (1,250) 0  
Proceeds from issuance of senior secured term loan       497,500 0  
Exchanges of convertible senior notes       (704) (40,461)  
Payment of deferred financing costs       (11,043) (11,545)  
Dividends on common stock       (197,757) (176,920)  
Dividends on preferred stock       (18,589) (20,505)  
Net cash (used in) provided by financing activities       1,094,475 707,773  
Net increase in cash and cash equivalents       51,128 21,517  
Cash and cash equivalents, beginning of period   $ 99,188   109,806 77,671 $ 99,188
Cash and cash equivalents, end of period 160,934 $ 109,806 99,188 160,934 99,188 160,934
Supplemental disclosure of cash flow information:            
Interest paid       96,201 77,219  
Supplemental disclosure of non-cash financing activities:            
Exchange of convertible senior notes for common stock       33,778 178,567  
Dividend declared, not yet paid 74,855   68,536 74,855 68,536 74,855
Offering costs payable $ 200   $ 265 200 265 $ 200
Loan proceeds held by servicer       3,323 0  
Deferred financing costs, not yet paid       $ 5,420 $ 0